Letters
Cancer drugs, survival, and ethics
Author’s reply to Dangoor and colleagues
BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6508 (Published 05 December 2016) Cite this as: BMJ 2016;355:i6508- Peter H Wise, physician (retired) and medical ethicist
- Charing Cross Hospital and Imperial College School of Medicine, London, UK
- wisepeter{at}hotmail.com
Dangoor and colleagues make some good points.1 2 My sources are indeed from different health systems—The BMJ is an international journal. I took care to validate all relevant material without prejudice, but I am happy to debate the validity of data from other sources.
Conflicts of interest are ethically important—above all in human, but also in …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.